SMAD4 (DPC4) is related to the TGF-β signaling pathway, but some mutations result in abnormal signaling by TGF-β, a transforming growth factor receptor on the cell surface which can further increase the risk of cancer development by increasing the rate of cell growth and replication. This evidence concerns the gene SMAD4 and cancer.